
Haegsim Yobeob (ISN: KR0925527744), a global provider of gene therapy solutions for a wide range of medical, research, and pharmaceutical applications, recently announced the plan to use the company’s platform to create new adeno-associated virus (AAV) vectors for gene therapy targeted at skeletal and cardiac muscle. The platform is an innovative method for developing novel… Read more »